Literature DB >> 29024412

Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.

Sangbin Han1, Sanghoon Lee2, Ju Dong Yang3, Michael Douglas Leise3, Joong Hyun Ahn4, Seonwoo Kim4, Kangha Jung1, Mi Sook Gwak1, Gaab Soo Kim1, Justin Sangwook Ko1.   

Abstract

Platelets interact with tumor cells and promote metastasis. The importance of platelets in posttransplant hepatocellular carcinoma (HCC) recurrence is unclear. Thus, we aimed to evaluate the association between preoperative platelet count (PLT) and HCC recurrence after living donor liver transplantation. Of 359 recipients of livers from living donors for HCC, 209 of 240 patients who had preoperative PLT ≤75 × 109 /L were matched with 97 of 119 patients who had preoperative PLT >75 × 109 /L using propensity score matching, with an unfixed matching ratio based on factors such as tumor biology. The cutoff value of 75 × 109 /L was set based on optimum stratification analysis. Survival analysis was performed with death as a competing risk event. The primary outcome was overall HCC recurrence. The median follow-up time was 59 months. Before matching, recurrence probability at 1, 2, and 5 years after transplantation was 4.7%, 9.2%, and 11.3% for the low platelet group and 14.5%, 23.0%, and 30.5% for the high platelet group. Recurrence risk was significantly greater in the high platelet group in both univariate (hazard ratio [HR] = 3.09; 95% confidence interval [CI], 1.86-5.14; P < 0.001) and multivariate analyses (HR = 2.10; 95% CI, 1.23-3.60; P =  0.007). In the matched analysis, recurrence risk was also greater in the high platelet group in both univariate (HR = 2.33; 95% CI, 1.36-4.01; P =  0.002) and multivariate analyses (HR = 1.90; 95% CI, 1.02-3.54; P =  0.04). Preoperative PLT had no interaction with the Milan criteria, alpha-fetoprotein level, Edmonson grade, microvascular invasion, or intrahepatic metastasis. Incorporation of preoperative PLT into the Milan criteria significantly improved predictive power. Inflammation-based scores including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and the inflammation-based index did not show superiority to preoperative PLT in predicting HCC recurrence. In conclusion, preoperative PLT appears to be an important host factor affecting HCC recurrence after living donor liver transplantation. Liver Transplantation 24 44-55 2018 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 29024412     DOI: 10.1002/lt.24961

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

1.  Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity.

Authors:  Kyo Won Lee; Sangbin Han; Sanghoon Lee; Hyun-Hwa Cha; Soohyun Ahn; Hyeon Seon Ahn; Justin Sangwook Ko; Mi Sook Gwak; Gaab Soo Kim; Jae-Won Joh; Suk-Koo Lee; Gyu-Seong Choi
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

2.  Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study.

Authors:  Linbin Lu; Yan Zhang; Peichan Zheng; Zhixian Wu; Xuewen Wang; Yaying Chen; Xiong Chen
Journal:  J Hepatocell Carcinoma       Date:  2020-10-15

3.  Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Authors:  Bernhard Scheiner; Martha Kirstein; Sabine Popp; Florian Hucke; Simona Bota; Nataliya Rohr-Udilova; Thomas Reiberger; Christian Müller; Michael Trauner; Markus Peck-Radosavljevic; Arndt Vogel; Wolfgang Sieghart; Matthias Pinter
Journal:  Liver Cancer       Date:  2018-06-22       Impact factor: 11.740

Review 4.  Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis.

Authors:  Quirino Lai; Fabio Melandro; Zoe Larghi Laureiro; Francesco Giovanardi; Stefano Ginanni Corradini; Flaminia Ferri; Redan Hassan; Massimo Rossi; Gianluca Mennini
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

Review 5.  Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.

Authors:  Quirino Lai; Alessandro Vitale; Tommaso M Manzia; Francesco G Foschi; Giovanni B Levi Sandri; Martina Gambato; Fabio Melandro; Francesco P Russo; Luca Miele; Luca Viganò; Patrizia Burra; Edoardo G Giannini
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

6.  Preoperative platelet count predicts posttransplant portal vein complications in orthotopic liver transplantation: a propensity score analysis.

Authors:  Qingshan Li; Yue Wang; Tao Ma; Fenggang Ren; Fan Mu; Rongqian Wu; Yi Lv; Bo Wang
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

7.  Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.

Authors:  Young Ri Kim; Sukhee Park; Sangbin Han; Joong Hyun Ahn; Seonwoo Kim; Dong Hyun Sinn; Woo Kyoung Jeong; Justin S Ko; Mi Sook Gwak; Gaab Soo Kim
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 8.  Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Maria J Citores; Jose L Lucena; Sara de la Fuente; Valentin Cuervas-Mons
Journal:  World J Hepatol       Date:  2019-01-27

9.  Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors.

Authors:  Chen-Liang Hu; Qian-Cheng Du; Zhi-Xin Wang; Ming-Quan Pang; Yan-Yan Wang; Ying-Yu Li; Ying Zhou; Hai-Jiu Wang; Hai-Ning Fan
Journal:  Oncol Lett       Date:  2020-01-17       Impact factor: 2.967

10.  Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study.

Authors:  Linbin Lu; Zhimin Su; Peichan Zheng; Zhixian Wu; Yan Zhang; Huimin He; Jingnan Liu; Shan Lin; Xiong Chen
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.